Niagen Bioscience Stock (NASDAQ:NAGE)


ForecastChartTranscripts

Previous Close

$3.19

52W Range

$3.12 - $11.29

50D Avg

$3.50

200D Avg

$5.27

Market Cap

$255.66M

Avg Vol (3M)

$857.32K

Beta

2.08

Div Yield

-

NAGE Company Profile


Niagen Bioscience Inc operates as a biotechnology enterprise with a core focus on promoting healthy aging. This company is also renowned for its pioneering research into nicotinamide adenine dinucleotide.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

117

IPO Date

Jun 24, 2015

Website

NAGE Performance


Latest Earnings Call Transcripts


Q1 26May 06, 26 | 12:00 AM
Q4 25Mar 04, 26 | 4:30 PM
Q3 25Nov 04, 25 | 4:30 PM

Peer Comparison


TickerCompany
RGNXREGENXBIO Inc.
RIGLRigel Pharmaceuticals, Inc.
PRTAProthena Corporation plc
AKBAAkebia Therapeutics, Inc.
VTYXVentyx Biosciences, Inc.
KROSKeros Therapeutics, Inc.
OLMAOlema Pharmaceuticals, Inc.
CRVSCorvus Pharmaceuticals, Inc.
ZVRAZevra Therapeutics, Inc.